摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-amino-4-(3',4'-dimethoxyphenyl)-6-pyrimidinone | 1369072-00-3

中文名称
——
中文别名
——
英文名称
2-amino-4-(3',4'-dimethoxyphenyl)-6-pyrimidinone
英文别名
2-Amino-6-(3,4-dimethoxyphenyl)pyrimidin-4-ol;2-amino-4-(3,4-dimethoxyphenyl)-1H-pyrimidin-6-one
2-amino-4-(3',4'-dimethoxyphenyl)-6-pyrimidinone化学式
CAS
1369072-00-3
化学式
C12H13N3O3
mdl
——
分子量
247.254
InChiKey
WHXFNLBTHUVWTP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.3
  • 重原子数:
    18
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.17
  • 拓扑面积:
    85.9
  • 氢给体数:
    2
  • 氢受体数:
    4

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-amino-4-(3',4'-dimethoxyphenyl)-6-pyrimidinone吡啶盐酸盐 作用下, 反应 1.0h, 以72%的产率得到2-amino-4-(3',4'-dihydroxyphenyl)-6-pyrimidinone
    参考文献:
    名称:
    Syntheses and electrochemical properties of novel aminopyrimidinone derivatives as a new class of abasic-site binders
    摘要:
    我们描述了新型氨基嘧啶酮衍生物的合成和电化学性质:2-氨基-4-(3′,4′-二甲氧基苯基)-6-嘧啶酮、2-氨基-4-(3′,4′-二羟基苯基)-6-嘧啶酮、2,4-二氨基-5-(3′,4′-二甲氧基苯基)-6-嘧啶酮、2,4-二氨基-5-(3′,4′-二羟基苯基)-6-嘧啶酮和4-氨基-5-(3′,4′-二羟基苯
    DOI:
    10.1007/s11164-012-0641-7
  • 作为产物:
    描述:
    盐酸胍3,4-二甲氧基苯甲酰乙酸乙酯potassium carbonate 作用下, 以 乙醇 为溶剂, 反应 48.0h, 以22%的产率得到2-amino-4-(3',4'-dimethoxyphenyl)-6-pyrimidinone
    参考文献:
    名称:
    Identification of novel isocytosine derivatives as xanthine oxidase inhibitors from a set of virtual screening hits
    摘要:
    In recent years, xanthine oxidase has emerged as an important target not only for gout but also for cardiovascular and metabolic disorders involving hyperuricemia. Contrary to popular belief, recent clinical trials with uricosurics have demonstrated that enhanced excretion of uric acid is, by itself, not adequate to treat hyperuricemia; simultaneous inhibition of production of uric acid by inhibition of xanthine oxidase is also important. Virtual screening of in-house synthetic library followed by in vitro and in vivo testing led to the identification of a novel scaffold for xanthine oxidase inhibition. In vitro activity results corroborated the results from molecular docking studies of the virtual screening hits. The isocytosine scaffold maintains key hydrogen bonding and pi-stacking interactions in the deep end of the xanthine-binding pocket, which anchors it in an appropriate pose to inhibit binding of xanthine and shows promise for further lead optimization using structure-based drug design approach. (C) 2012 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2012.03.019
点击查看最新优质反应信息

文献信息

  • Identification of novel isocytosine derivatives as xanthine oxidase inhibitors from a set of virtual screening hits
    作者:Chandrika B-Rao、Asha Kulkarni-Almeida、Kamlesh V. Katkar、Smriti Khanna、Usha Ghosh、Ashish Keche、Pranay Shah、Ankita Srivastava、Vaidehi Korde、Kumar V.S. Nemmani、Nitin J. Deshmukh、Amol Dixit、Manoja K. Brahma、Umakant Bahirat、Lalit Doshi、Rajiv Sharma、H. Sivaramakrishnan
    DOI:10.1016/j.bmc.2012.03.019
    日期:2012.5
    In recent years, xanthine oxidase has emerged as an important target not only for gout but also for cardiovascular and metabolic disorders involving hyperuricemia. Contrary to popular belief, recent clinical trials with uricosurics have demonstrated that enhanced excretion of uric acid is, by itself, not adequate to treat hyperuricemia; simultaneous inhibition of production of uric acid by inhibition of xanthine oxidase is also important. Virtual screening of in-house synthetic library followed by in vitro and in vivo testing led to the identification of a novel scaffold for xanthine oxidase inhibition. In vitro activity results corroborated the results from molecular docking studies of the virtual screening hits. The isocytosine scaffold maintains key hydrogen bonding and pi-stacking interactions in the deep end of the xanthine-binding pocket, which anchors it in an appropriate pose to inhibit binding of xanthine and shows promise for further lead optimization using structure-based drug design approach. (C) 2012 Elsevier Ltd. All rights reserved.
  • Syntheses and electrochemical properties of novel aminopyrimidinone derivatives as a new class of abasic-site binders
    作者:Junya Chiba、Yasuhiro Doi、Masahiko Inouye
    DOI:10.1007/s11164-012-0641-7
    日期:2013.1
    We describe syntheses and electrochemical properties of a new class of aminopyrimidinone derivatives: 2-amino-4-(3′,4′-dimethoxyphenyl)-6-pyrimidinone, 2-amino-4-(3′,4′-dihydroxyphenyl)-6-pyrimidinone, 2,4-diamino-5-(3′,4′-dimethoxyphenyl)-6-pyrimidinone, 2,4-diamino-5-(3′,4′-dihydroxyphenyl)-6-pyrimidinone, and 4-amino-5-(3′,4′-dihydroxyphenyl)-2,6-pyrimidinione, three of which possess a catechol unit as an oxidation-active moiety for developing electrochemically detectable abasic-site binders. These compounds were synthesized via a pyrimidine-ring forming reaction with guanidine. Cyclic voltammetry measurements revealed that the catechol-bearing derivatives showed oxidation potentials lower than that of DNA, indicating that they satisfied the requirements for the purpose.
    我们描述了新型氨基嘧啶酮衍生物的合成和电化学性质:2-氨基-4-(3′,4′-二甲氧基苯基)-6-嘧啶酮、2-氨基-4-(3′,4′-二羟基苯基)-6-嘧啶酮、2,4-二氨基-5-(3′,4′-二甲氧基苯基)-6-嘧啶酮、2,4-二氨基-5-(3′,4′-二羟基苯基)-6-嘧啶酮和4-氨基-5-(3′,4′-二羟基苯
查看更多